Negative influence of age and low baseline CD4 on T helper cell recovery among HIV-infected individuals with fixed-dose combination of tenofovir disoproxil, lamivudine and dolutegravir

The study highlights that, despite viral suppression with TLD, a substantial proportion of patients fail to achieve adequate immune restoration. Lower baseline CD4 was observed to be a key predictor of DIR. These findings underscore the need for early ART initiation, targeted adherence support, and counselling to optimize outcomes and progress toward the UNAIDS 95 target.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-02-26
DOI
https://doi.org/10.3389/fpubh.2026.1729238
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Negative influence of age and low baseline CD4 on T helper cell recovery among HIV-infected individuals with fixed-dose combination of tenofovir disoproxil, lamivudine and dolutegravir

Yean Kong Yong, Vijayakumar Velu, Marie Larsson, Sivadoss Raju et al.
Frontiers in Public Health
HIV/AIDS drug development and treatment
article

Negative influence of age and low baseline CD4 on T helper cell recovery among HIV-infected individuals with fixed-dose combination of tenofovir disoproxil, lamivudine and dolutegravir

Yean Kong Yong, Vijayakumar Velu, Marie Larsson, Sivadoss Raju, B Nisha, Sathasivam Sivamalar, Princy Mounika, Ramachandran Vignesh, Kannan Rajendran, Esaki M. Shankar, Venkatesan Varsha, Arcot R. Venkateswaran, Thiyagarajan Vivekanandan, Madhavan Vidya, Pachamuthu Balakrishnan, Sakthi Rengarajan
article en

Abstract

The study highlights that, despite viral suppression with TLD, a substantial proportion of patients fail to achieve adequate immune restoration. Lower baseline CD4 was observed to be a key predictor of DIR. These findings underscore the need for early ART initiation, targeted adherence support, and counselling to optimize outcomes and progress toward the UNAIDS 95 target.

Frontiers in Public HealthVol. 14
Linköping University (SE), Emory and Henry College (US), Meenakshi Academy of Higher Education and Research (IN), Institut thématique Immunologie, inflammation, infectiologie et microbiologie (FR), Xiamen University Malaysia (MY), New England Biolabs (China) (CN), Public Health Laboratory, University of Kuala Lumpur (MY), Saveetha University (IN)
Emory University, Xiamen University, National Institutes of Health, Office of Research Infrastructure Programs, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 42%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.